Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1997-08-14
Original market date: See footnote 1
1987-12-31
Product name:
MTE 4 INJ
DIN:
01945319 Electronic product monograph is not available
Company:
LYPHOMED, DIVISION OF FUJISAWA CANADA INC.
800
625 Cochrane Drive
Markham
Ontario
Canada
L3R 9R9
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
4
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
88:29.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA30 COMBINATIONS OF ELECTROLYTES
Active ingredient group (AIG) number:See footnote5
0414689003
Active ingredient(s) See footnote8 | Strength |
---|---|
CHROMIUM (CHROMIUM SULFATE) | 4 MCG / ML |
COPPER (CUPRIC SULFATE) | .4 MG / ML |
MANGANESE (MANGANESE SULFATE) | .1 MG / ML |
ZINC (ZINC SULFATE) | 1 MG / ML |